中国麻风皮肤病杂志
中國痳風皮膚病雜誌
중국마풍피부병잡지
CHINA JOURNAL OF LEPROSY AND SKIN DISEASES
2014年
9期
558-559
,共2页
扁平疣%香蓝驱毒颗粒%T淋巴细胞亚群%白细胞介素-2
扁平疣%香藍驅毒顆粒%T淋巴細胞亞群%白細胞介素-2
편평우%향람구독과립%T림파세포아군%백세포개소-2
varruca plana%Xianglan Qudu Keli%T lymphocyte subsets%IL-2
目的:评价香蓝驱毒颗粒对扁平疣患者外周血T细胞亚群和IL-2的影响。方法:对120例扁平疣患者给予香蓝驱毒颗粒30 g,每日2次,治疗6周。检测治疗前后扁平疣患者外周血T细胞亚群及IL-2水平。结果:治疗前患者外周血CD4+细胞数为32.25±1.83、CD4+/CD8+比值0.79±0.26及IL-2水平为2.24±0.68。治疗后上述3个参数分别为39.89±1.25、1.68±0.21和4.44±0.62,均显著升高( P<0.01)。结论:香蓝驱毒颗粒能增强扁平疣患者的免疫功能及T细胞介导的免疫反应。
目的:評價香藍驅毒顆粒對扁平疣患者外週血T細胞亞群和IL-2的影響。方法:對120例扁平疣患者給予香藍驅毒顆粒30 g,每日2次,治療6週。檢測治療前後扁平疣患者外週血T細胞亞群及IL-2水平。結果:治療前患者外週血CD4+細胞數為32.25±1.83、CD4+/CD8+比值0.79±0.26及IL-2水平為2.24±0.68。治療後上述3箇參數分彆為39.89±1.25、1.68±0.21和4.44±0.62,均顯著升高( P<0.01)。結論:香藍驅毒顆粒能增彊扁平疣患者的免疫功能及T細胞介導的免疫反應。
목적:평개향람구독과립대편평우환자외주혈T세포아군화IL-2적영향。방법:대120례편평우환자급여향람구독과립30 g,매일2차,치료6주。검측치료전후편평우환자외주혈T세포아군급IL-2수평。결과:치료전환자외주혈CD4+세포수위32.25±1.83、CD4+/CD8+비치0.79±0.26급IL-2수평위2.24±0.68。치료후상술3개삼수분별위39.89±1.25、1.68±0.21화4.44±0.62,균현저승고( P<0.01)。결론:향람구독과립능증강편평우환자적면역공능급T세포개도적면역반응。
Objective: To determine the influence of Xianglan Qudu Keli on the levels of T lymphocyte subsets and IL-2 in peripheral blood of the patients with varruca plana. Methods: One hundred and twenty patients with varruca plana were treated with Xianglan Qudu Keli, 30g twice a day for 6 weeks. T lymphocyte subsets and IL-2 level in peripheral blood of patients were detected before and after treatment. Results: Be-fore treatment, the CD4+ cell number was 32.25±1.83, the ratio of CD4+/CD8+ was 0.79±0.26 and the level of IL-2 was 2.24±0.68. After treatment, the CD4+cell number was 39.89±1.25, the ratio of CD4+/CD8+was 1.68±0.21 and the level of IL-2 was 4.44±0.62, which was significantly increased that those before treatment ( P<0.01) . Conclusion:Xianglan Qudu Keli can enhance cellular immunity and T cell-mediated immune re-sponse in the patients with varruca plana.